Part 2: Post-transplant Lymphoproliferative Disorders
Namrata M. Shah, MD, MPH
Hematology/Oncology Fellow, Medical College of Wisconsin, Milwaukee, WI
Timothy S. Fenske, MD
Associate Professor of Medicine, Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI
Which of the following factors is/are associated with an unfavorable prognosis in PTLD after solid organ transplant?